Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most important factor in how much weight you lose on Wegovy is not the pen itself — it is what you do alongside it. Most people on semaglutide 2.4mg achieve average reductions of around 15% of body weight over 68 weeks, as reported in the STEP 1 trial published in the New England Journal of Medicine, but outcomes vary considerably depending on diet, activity, sleep and consistency with the titration schedule. Wegovy is a prescription-only medicine: a GPhC-registered prescriber assesses whether it is clinically appropriate for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide slows how quickly food leaves your stomach and reduces appetite through GLP-1 receptor pathways. That combination makes eating less feel natural rather than effortful for most people. The risk is eating too little rather than too much, and eating too little of the wrong things.
When total calories fall sharply, the body can lose lean muscle alongside fat. Prioritising protein at every meal (eggs, fish, legumes, Greek yoghurt, chicken) gives your body the building blocks to protect that muscle. The NHS healthy weight guidance recommends that any reduced-calorie approach still covers nutritional basics: fibre from vegetables and wholegrains, adequate fluid, and not skipping meals to the point of dizziness or fatigue.
A quick habit worth building: before each meal, check whether there is a source of protein on the plate. That single scan (under ten seconds) shapes the whole nutritional pattern over months without requiring meticulous tracking.
Processed foods high in refined sugar can still be eaten in smaller quantities on Wegovy, but they do not fill you for long, and cravings can reassert themselves once the hormonal dampening is less acute. Whole foods with fibre and protein keep satiety working in your favour between doses.
Aerobic activity burns calories; resistance training builds and preserves the muscle that keeps your metabolism higher as weight falls. On a GLP-1 medicine, the combination is more powerful than either alone. You do not need a gym membership. Body-weight exercises, walking with a weighted rucksack, or swimming all count.
The practical difficulty is energy. Some people feel tired in the first few weeks after a dose increase, particularly during the early titration steps. Short, consistent sessions (even 20 minutes three times a week) outperform ambitious plans that get abandoned. Build the habit first; the duration extends naturally.
There is useful detail on what typical weight loss on Wegovy looks like over the full treatment course, including how the rate of loss tends to change as doses increase. Understanding that pattern helps set realistic expectations for each phase rather than measuring success only at the end.
One underappreciated point: muscle mass is metabolically active tissue. People who do some resistance work during treatment tend to maintain their results better after stopping, because their resting energy expenditure has not fallen as sharply.
Wegovy starts at 0.25mg and escalates through 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose, typically over around five months. The higher doses drive the majority of the weight loss, and our guide on how much weight loss is achievable on Wegovy explains what the clinical evidence shows patients can realistically expect at full dose. Patients who stop escalating (often because of gastrointestinal side effects at an intermediate dose) usually see slower results than those who reach maintenance.
Side effects like nausea, loose stools or reflux are real, and they are also usually manageable. Eating smaller portions, avoiding fatty or very rich food around injection day, and staying hydrated all help. The NHS patient information for semaglutide covers which symptoms are expected and which warrant a call to your prescriber. Most of the gastrointestinal discomfort peaks in the first week or two after each step up, then settles.
If you are considering Wegovy or are already on it and wondering whether you are at the right stage, our overview of how long Wegovy takes to work sets out what to expect at each phase. Speaking to your prescriber rather than pausing or reducing your dose on your own initiative is the safer route when side effects feel difficult.
For context on what the treatment costs and how private prescribing works, the Wegovy price comparison page explains what a legitimate private prescription includes and what market prices typically cover. Treatment is a prescription-only medicine and requires clinical assessment before it can be dispensed.
Cortisol (the stress hormone) promotes fat storage, particularly around the abdomen. Chronic poor sleep raises cortisol and disrupts ghrelin and leptin, the hormones that signal hunger and fullness. Semaglutide operates through a different pathway, but it does not override these signals entirely. People who are sleeping four or five hours a night regularly tend to find appetite suppression less consistent than those sleeping seven or eight.
This is not an argument for perfectionism. Life is not a clinical trial. But addressing sleep if it is genuinely poor (treating it as part of the weight-management plan rather than a separate problem) does make a measurable difference to outcomes over a year-long treatment course.
Alcohol is worth noting too. It adds calories with no nutritional return, can worsen GI side effects, and disrupts sleep quality even when the amount feels modest. Cutting back rather than eliminating it entirely is a reasonable middle position for most people.
If you are not seeing progress despite doing the above consistently, the guide to stalled weight loss on Wegovy works through the most common clinical and practical reasons, and our dedicated page on how to maximise weight loss on Wegovy pulls together the practical steps that make the most difference across the full treatment course. And if you are weighing up whether Wegovy or tirzepatide is the right starting point, our weight-loss treatment overview sets out what each option offers and how a prescriber makes that recommendation.
Our clinical team reviews every consultation personally. If you would like to explore whether Wegovy is appropriate for you, start your free consultation and a GPhC-registered prescriber will assess your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.